Skip to main content

Table 4 Hospital costs (£), quality-adjusted life years (QALY) and incremental net benefit up to 6 months and over patients’ lifetime for trial participants

From: Cost-effectiveness of a cardiac output-guided haemodynamic therapy algorithm in high-risk patients undergoing major gastrointestinal surgery

 

Peri-operative cardiac output-guided haemodynamic therapy

Usual care

Incremental effect

(n = 368)

(n = 365)

Up to 6 months

   

Costs (£)

8574 (6304)

8974 (7217)

−404 (−1313 to 505)

QALY

0.37 (0.11)

0.36 (0.12)

0.01 (0.00 to 0.02)

Incremental net benefit

  

580 (−378 to 1538)

Lifetime

   

Costs (£)

8574 (6304)

8974 (7217)

−404 (−1313 to 504)

QALY

7.59 (3.34)

7.10 (3.60)

0.19 (−0.17 to 0.54)

Incremental net benefit

  

4168 (−3063 to 11,398)

  1. Data presented as mean (SD) and mean (95 % confidence intervals)